Your browser doesn't support javascript.
loading
Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria.
Gericke, Janine; Metz, Martin; Ohanyan, Tatevik; Weller, Karsten; Altrichter, Sabine; Skov, Per Stahl; Falkencrone, Sidsel; Brand, Janko; Kromminga, Arno; Hawro, Tomasz; Church, Martin K; Maurer, Marcus.
Afiliação
  • Gericke J; Department of Dermatology, Venerology and Allergy, Allergie-Centrum Charité, Charité - Universitätsmedizin, Berlin, Germany.
  • Metz M; Department of Dermatology, Venerology and Allergy, Allergie-Centrum Charité, Charité - Universitätsmedizin, Berlin, Germany.
  • Ohanyan T; Department of Dermatology, Venerology and Allergy, Allergie-Centrum Charité, Charité - Universitätsmedizin, Berlin, Germany.
  • Weller K; Department of Dermatology, Venerology and Allergy, Allergie-Centrum Charité, Charité - Universitätsmedizin, Berlin, Germany.
  • Altrichter S; Department of Dermatology, Venerology and Allergy, Allergie-Centrum Charité, Charité - Universitätsmedizin, Berlin, Germany.
  • Skov PS; Dermatological Department, University Hospital of Southern Denmark, Odense, Denmark; RefLab ApS, Copenhagen, Denmark; Institute of Immunology, National University of Copenhagen, Copenhagen, Denmark.
  • Falkencrone S; RefLab ApS, Copenhagen, Denmark.
  • Brand J; BioTeZ Berlin-Buch GmbH, Berlin, Germany.
  • Kromminga A; IPM Biotech GmbH, Hamburg, Germany.
  • Hawro T; Department of Dermatology, Venerology and Allergy, Allergie-Centrum Charité, Charité - Universitätsmedizin, Berlin, Germany.
  • Church MK; Department of Dermatology, Venerology and Allergy, Allergie-Centrum Charité, Charité - Universitätsmedizin, Berlin, Germany.
  • Maurer M; Department of Dermatology, Venerology and Allergy, Allergie-Centrum Charité, Charité - Universitätsmedizin, Berlin, Germany. Electronic address: marcus.maurer@charite.de.
J Allergy Clin Immunol ; 139(3): 1059-1061.e1, 2017 03.
Article em En | MEDLINE | ID: mdl-27838346
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Urticária / Antialérgicos / Omalizumab Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Urticária / Antialérgicos / Omalizumab Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha